NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/24/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization27.64 mln
Float32.33 mln
Earnings Date11/11/2026
Piotroski F-Score
1
/ 9
Very weak
Beneish M-Score
-1.37
Manipulation likely
Relative Strength
2
/ 100
Severely lagging
Debt / Equity
-2.11
Negative equity
ROE
-7,414
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Dyadic International is a US-based biotechnology company that develops and sells industrial enzymes and biological products for use in pharmaceuticals, food and nutrition, and industrial markets worldwide. Its core technology is the C1 platform, a protein production system that enables fast, large-scale manufacturing of biologics at competitive costs. The company is advancing a COVID-19 vaccine candidate through clinical trials and maintains active partnerships with research institutions and biotech firms across Europe, Africa, and beyond. Founded in 1979, Dyadic is headquartered in Jupiter, Florida.
